Also known as: Rifampin; Rimactane; Rifadin
Rifampicin is a pharmaceutical-grade active ingredient classified as a broad-spectrum Rifamycin Antibiotic. Mediocon Inc supplies high-purity Rifampicin API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.
Rifampicin (Rifampin) is a semisynthetic antibiotic derived from Amycolatopsis rifamycinica. It is a first-line antituberculosis drug and is also used in treatment of leprosy, brucellosis, Legionnaire's disease, and as prophylaxis for Meningococcal meningitis. It acts by inhibiting bacterial RNA polymerase, preventing transcription.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Rifampicin (CAS 13292-46-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Rifampicin is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance